Motawea et al. conducted a meta-analysis and reported a statistically significant association between IBS and increased prevalence of GnRH IgM antibodies (risk ratio = 2.29) (Motawea et al., 2022). The gene discussed is GNRH1; the disease is irritable bowel syndrome.